These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 11479245

  • 1. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N, Lim PO, MacDonald TM.
    Circulation; 2001 Jul 31; 104(5):511-4. PubMed ID: 11479245
    [Abstract] [Full Text] [Related]

  • 2. Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study.
    Tzemos N, Lim PO, MacDonald TM.
    Cardiovasc Ther; 2009 Jul 31; 27(3):151-8. PubMed ID: 19604249
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L, Cléroux J, Nadeau A, Lacourcière Y.
    J Hypertens; 2001 Aug 31; 19(8):1429-35. PubMed ID: 11518851
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
    Cosentino F, Bonetti S, Rehorik R, Eto M, Werner-Felmayer G, Volpe M, Lüscher TF.
    J Hypertens; 2002 Mar 31; 20(3):421-8. PubMed ID: 11875309
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of AT1 receptor blockade on endothelial function in essential hypertension.
    Klingbeil AU, John S, Schneider MP, Jacobi J, Handrock R, Schmieder RE.
    Am J Hypertens; 2003 Feb 31; 16(2):123-8. PubMed ID: 12559678
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
    Dawes M, Brett SE, Chowienczyk PJ, Mant TG, Ritter JM.
    Br J Clin Pharmacol; 1999 Sep 31; 48(3):460-3. PubMed ID: 10510163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L, Wooding SJ, Ritter JM.
    J Pharmacol Exp Ther; 1995 Sep 31; 274(3):1067-71. PubMed ID: 7562470
    [Abstract] [Full Text] [Related]

  • 17. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.
    Merchant N, Searles CD, Pandian A, Rahman ST, Ferdinand KC, Umpierrez GE, Khan BV.
    J Clin Hypertens (Greenwich); 2009 Dec 31; 11(12):720-5. PubMed ID: 20021529
    [Abstract] [Full Text] [Related]

  • 18. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A.
    Circulation; 1998 Jun 09; 97(22):2222-9. PubMed ID: 9631871
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients.
    Zanchetti A.
    Blood Press Suppl; 2004 Oct 09; 1():17-32. PubMed ID: 15587108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.